Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 5, 2005 - Issue 5
Submit an article Journal homepage
92
Views
6
CrossRef citations to date
0
Altmetric
Review

Investigational agents for epithelial ovarian cancer

Franco Muggia New York University Clinical Cancer Center, 462 First Avenue, Building BCD, Room 556, NY 10016-9196, USA. [email protected]
&
Rebecca Kosloff New York University Clinical Cancer Center, 462 First Avenue, Building BCD, Room 556, NY 10016-9196, USA. [email protected]
Pages 855-868 | Published online: 10 Jan 2014

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Domenica Lorusso, Antonella Pietragalla, Sara Mainenti, Alessia Di Legge, Giulia Amadio & Giovanni Scambia. (2010) Emerging drugs for ovarian cancer. Expert Opinion on Emerging Drugs 15:4, pages 635-652.
Read now

Articles from other publishers (5)

B.T. Hennessy & M. Markman. (2009) Development of novel agents for ovarian cancer. Update on Cancer Therapeutics 3:3, pages 119-132.
Crossref
Xiao-Feng Li, Sean Carlin, Muneyasu Urano, James Russell, C. Clifton Ling & Joseph A. O'Donoghue. (2007) Visualization of Hypoxia in Microscopic Tumors by Immunofluorescent Microscopy. Cancer Research 67:16, pages 7646-7653.
Crossref
F. Legge, D. Eaton, R. Molife, G. Ferrandina, I. Judson, J. de Bono & S. Kaye. (2007) Participation of patients with gynecological cancer in phase I clinical trials: Two years experience in a major cancer center. Gynecologic Oncology 104:3, pages 551-556.
Crossref
Maria Kyrgiou, Georgia Salanti, Nicholas Pavlidis, Evangelos Paraskevaidis & John P. A. Ioannidis. (2006) Survival Benefits With Diverse Chemotherapy Regimens for Ovarian Cancer: Meta-analysis of Multiple Treatments. JNCI: Journal of the National Cancer Institute 98:22, pages 1655-1663.
Crossref
Edward L. Trimble & Ronald D. Alvarez. (2006) Intraperitoneal chemotherapy and the NCI clinical announcement. Gynecologic Oncology 103:2, pages 18-19.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.